rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6-7
|
pubmed:dateCreated |
2009-5-11
|
pubmed:abstractText |
Deposition of amyloid-beta peptide (Abeta) in the diabetic brain is poorly understood. Low-density lipoprotein receptor related protein 1(LRP1) at the blood-brain barrier (BBB) is critical for regulation of Abeta homeostasis in the brain. In this study, we used streptozotocin-induced diabetic mice to observe the expression of LRP1 at the BBB by Western blot and immunocytochemical analysis, and to study in vivo brain-to-blood efflux transport of 125I-Abeta1-40 using brain clearance studies. In the diabetic mice with hyperglycemia (>16.0 mmol/l) at 6 weeks, LRP1 expression at the BBB was significantly downregulated; no significant changes of LRP1 levels were found at 1 and 3 weeks after diabetes induction. The data of brain clearance studies for Abeta showed significant decrease in LRP1-dependent transport of Abeta across the BBB at 6 weeks after diabetes induction, while no significant changes of LRP1-dependent transport of Abeta across the BBB at 1 or 3 weeks after diabetes induction were apparent. We conclude that the downregulation of LRP1 at the BBB contributes to cerebral Abeta deposition in diabetes mellitus.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1873-7064
|
pubmed:author |
pubmed-author:HongHaoH,
pubmed-author:LiYong QiYQ,
pubmed-author:LiaoJian MingJM,
pubmed-author:LiuLi PingLP,
pubmed-author:LongYanY,
pubmed-author:WangTong ShengTS,
pubmed-author:WangYing YuYY,
pubmed-author:WangYingY,
pubmed-author:WuJingJ,
pubmed-author:XiaYuan ZhengYZ,
pubmed-author:YeFeng YingFY
|
pubmed:issnType |
Electronic
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1054-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19285094-Amyloid beta-Peptides,
pubmed-meshheading:19285094-Animals,
pubmed-meshheading:19285094-Biological Transport,
pubmed-meshheading:19285094-Blood-Brain Barrier,
pubmed-meshheading:19285094-Diabetes Mellitus, Experimental,
pubmed-meshheading:19285094-Down-Regulation,
pubmed-meshheading:19285094-Humans,
pubmed-meshheading:19285094-Male,
pubmed-meshheading:19285094-Mice,
pubmed-meshheading:19285094-Mice, Inbred C57BL,
pubmed-meshheading:19285094-Peptide Fragments,
pubmed-meshheading:19285094-Receptors, LDL,
pubmed-meshheading:19285094-Streptozocin,
pubmed-meshheading:19285094-Tumor Suppressor Proteins
|
pubmed:articleTitle |
Downregulation of LRP1 [correction of LPR1] at the blood-brain barrier in streptozotocin-induced diabetic mice.
|
pubmed:affiliation |
Department of Pharmacology, China Pharmaceutical University, Tong Jiaxiang, Nanjing 210009, PR China. haohongchina@hotmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|